Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Perrigo(PRGO) Prnewswire·2024-04-25 18:00Perrigo(PRGO) Prnewswire·2024-04-25 18:00
R1Perrigo(PRGO) Prnewswire·2024-04-25 18:00 R1Perrigo(PRGO) Prnewswire·2024-04-25 18:00